Introduction: According to statistics damage venous circulation of the lower extremities are among the most common diseases in the world. Although the treatment varicose veins (VV) modernized using non-invasive-endovenous procedures, forecast on short term is not quite satisfactory. Aim of this study was to examine the results of treatment vv lower extremities to the appearance of improving the quality of life and the emergence of recurrence 1 year after operating (OP) and endovenous laser ablation (EVLA) treatment. Methods: VV patients who were operated classic surgical method (OP) were the OP group (n-36) and the patients who were treated EVLA method were the EVLA group (n-36). We studied quality of life the patients after 1 year of treatment by Aberdeen's questionnaire and the occurrence of recurrence. Results: Between the two groups there was no difference in terms of risk factors before OP / EVLA treatment, as well as in terms of disease severity assessed CEAP classifi cation. Quality of life after 1 year showed that there were no differences between the two groups (5.288 / 7.444, p <0.076). However, symptoms of patients in both groups improved after 1 year of intervention, the pain is to reduce the OP group to 61%, in EVLA group by 87% (p <0.017) Also, after 1 year there was no signifi cant difference in recurrence occurs between OP and EVLA group. (10/36 to 27.8% in the group of OP 6/36 to 16.7 %% in EVLA group). Of the risk factors in multivariate analysis on the phenomenon of recurrence a previous deep vein thrombosis was signifi cantly infl uenced (p = 0.011). Conclusion: Patients after 1 year of treatment OP or EVLA of varicose veins had signifi cantly fewer symptoms, particularly patients who were EVLA group Differences between groups were not signifi cant in terms of the recurrence and the quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.